A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab-Reference-Cited by-同舟云学术

A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab

Published:2019-07-16 Issue:1 Volume:7 Page:
ISSN:2050-7771
Container-title:Biomarker Research
language:en
Short-container-title:Biomark Res

Author:

Espinosa-Cotton Madelyn,Fertig Elana J.,Stabile Laura P.,Gaither-Davis Autumn,Bauman Julie E.,Schmitz Sandra,Gibson-Corley Katherine N.,Cheng Yinwen,Jensen Isaac J.,Badovinac Vladimir P.,Laux Douglas,Simons Andrean L.

Funder

American Association for Cancer Research

National Institute of Dental and Craniofacial Research

National Cancer Institute

National Institute of Allergy and Infectious Diseases

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry, medical,Clinical Biochemistry,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40364-019-0164-0.pdf

Reference52 articles.

1. Prewett M, Rockwell P, Rockwell RF, Giorgio NA, Mendelsohn J, Scher HI, et al. The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma. J Immunother Emphasis Tumor Immunol. 1996;19:419–27.

2. Riemer AB, Kurz H, Klinger M, Scheiner O, Zielinski CC, Jensen-Jarolim E. Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies. J Natl Cancer Inst. 2005;97:1663–70.

3. Kawaguchi Y, Kono K, Mimura K, Sugai H, Akaike H, Fujii H. Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma. Int J Cancer. 2007;120:781–7.

4. Wang W, Erbe AK, Hank JA, Morris ZS, Sondel PM. NK cell-mediated antibody-dependent cellular cytotoxicity in Cancer immunotherapy. Front Immunol. 2015;6:368.

5. Srivastava RM, Lee SC, Andrade Filho PA, Lord CA, Jie HB, Davidson HC, et al. Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients. Clin Cancer Res. 2013;19:1858–72.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Cytokinome in the HNSCC Tumor Microenvironment: A Narrative Review and Our Experience;Diagnostics;2022-11-21

2. Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC;Frontiers in Immunology;2022-10-03

3. The Assessment of Serum Cytokines in Oral Squamous Cell Carcinoma Patients: An Observational Prospective Controlled Study;Journal of Clinical Medicine;2022-09-14

4. The Role of Immune Modulatory Cytokines in the Tumor Microenvironments of Head and Neck Squamous Cell Carcinomas;Cancers;2022-06-11

5. Interleukin‐33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancer;Cancer Medicine;2021-10-19